April 15 Plenary Congress Day 1

MORNING PLENARIES RENAISSANCE BALLROOM

Gregory Poland
08:20

Chair’s opening remarks

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
Brett Giroir
08:30

Strengthening the effectiveness of national, state & local efforts to improve the uptake of HPV vaccination

Panel discussion
08:45

Plenary keynote insights: What direction will vaccines take to ensure safety and mass immunization

  • Vaccine Research and Development in the Public Sector
  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development
Panel discussion
10:45

Networking Coffee Break

INTERACTIVE ROUNDTABLES

11:45

Artificial intelligence -adopting cognitive computing across the PV landscape

11:45

Changing landscape of real-world evidence and its impact on clinical research – uncovering lab & clinical adverse events

Dr James Cummings
11:45

Developing more effective vaccines for emerging/re-emerging pandemic threats

Dr James F. Cummings, MD, President, ICON Government and Public Health Solutions – title TBC
11:45

Development of novel predictive algorithms for patient selection

Jason Berg
11:45

Identifying the ideal vaccine research site – lessons learned from the field

Senior representative, PPD
Dr Richard Kennedy
11:45

Immune Profiling - capturing the complexity of immune responses to vaccines and infections

Prof Ab Osterhaus
11:45

Impact of influenza vaccination on antibiotic use and AMR reduction

Prof Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover
Dr Michael Salgaller
11:45

Oncology – applying precision medicine and informatics to find the best treatment option for each patient

11:45

Overcoming obstacles to improve cold chain management of biologics

11:45

Pediatric Vaccine Trials – Recruitment and Retention

Dr Nathalie Garcon
11:45

Safety evaluation of vaccines: from now to tomorrow, new approaches and technologies?

Dr Nathalie Garcon, CSO & CEO, Bioaster
Cynthia Dukes
11:45

Seasonal vaccine studies: Critical success factors

Cynthia Dukes, VP, Scientific and Clinical Services and Head of Vaccine Center of Excellence, ICON Clinical Research – title TBC
Dr Jun Tang
11:45

When limited patient resources meet unlimited immunotherapy combinations—the strategies to develop clinical IO agents in platform studies

13:10

Networking Lunch (Exhibition Hall)

AFTERNOON PLENARIES

Panel discussion
14:40

The role of vaccines to combat antibiotic-microbial resistance

  • What can we do to manage AMR? The mis-use of Abx in bacterial and viral infections
  • How vaccine regulatory and access policies can be used to strengthen utilization of vaccines as a component of multi-pronged strategies that governments should take in their national action plans to address AMR
  • The need for a holistic and collaborative strategy including cross species considerations
Panel discussion
16:30

Networking Coffee Break

AFTERNOON PLENARIES

ONE HEALTH

Plenary afternoon day 1
17:00

The continuing instrumental role of NGOs: Making the impossible, achievable

  • What global market trends can we expect in the next 10 years? What does this mean for vaccines?
  • Impact of emerging diseases, AMR and measles outbreaks
  • Ongoing efforts towards developing world diseases and child health
  • Strengthening of primary health care systems
Plenary afternoon day 1
17:50

The resurgence of immuno-oncology – Can they hold their promise?

  • How will recent breakthroughs in immuno-oncology shape the way we design cancer vaccines and combinational treatments?
  • Are our expectations vs the reality of immunotherapies working aligned?
  • How can we better characterize post-treatment analysis of anti-tumor immune responses to develop more effective immunotherapy approaches?
  • Advancements in personalized neoantigen vaccines and novel targets
ONE HEALTH
17:50

Operational framework for strengthening human & animal public health systems at their interface

  • What tools and resources from the human health, animal health, and disaster risk reduction sectors can facilitate multi-sectoral coordination?
  • Strategy for appropriate One Health entry points and a pathway to the prevent-detect-respond-recover spectrum of preparedness
  • What public health system changes do we need to truly facilitate a One Health approach?
18:40

Chair’s Closing Remarks and Close of Congress Day 1

18:50

Pre-Awards Networking Drinks Reception (off-site)

19:30

Gala Dinner & 12th Annual ViE Awards Ceremony

last published: 21/Mar/19 15:25 GMT

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071